Adverum Biotechnologies IncNASDAQ:ADVMNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE1.1200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 1.1200
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ADVM |
|---|---|---|
| 09:32 ET | 34051 | 1.13 |
| 09:34 ET | 500 | 1.1299 |
| 09:43 ET | 100 | 1.1286 |
| 09:45 ET | 15560 | 1.13 |
| 09:48 ET | 24295 | 1.12 |
| 09:50 ET | 394 | 1.14 |
| 09:52 ET | 599 | 1.13 |
| 09:54 ET | 1900 | 1.11 |
| 09:57 ET | 1529 | 1.13 |
| 09:59 ET | 100 | 1.12 |
| 10:01 ET | 1000 | 1.127 |
| 10:06 ET | 2209 | 1.1163 |
| 10:08 ET | 36380 | 1.1576 |
| 10:10 ET | 4130 | 1.15 |
| 10:12 ET | 7344 | 1.16 |
| 10:14 ET | 10276 | 1.14 |
| 10:15 ET | 282 | 1.15 |
| 10:17 ET | 4200 | 1.14 |
| 10:21 ET | 1354 | 1.1502 |
| 10:28 ET | 392 | 1.16 |
| 10:30 ET | 26944 | 1.14 |
| 10:32 ET | 200 | 1.16 |
| 10:33 ET | 700 | 1.14 |
| 10:37 ET | 9764 | 1.165 |
| 10:39 ET | 1694 | 1.15 |
| 10:44 ET | 100 | 1.15 |
| 10:48 ET | 100 | 1.154 |
| 10:53 ET | 3326 | 1.17 |
| 10:55 ET | 500 | 1.16 |
| 10:57 ET | 2300 | 1.1651 |
| 11:02 ET | 1000 | 1.1609 |
| 11:04 ET | 6101 | 1.165 |
| 11:06 ET | 28623 | 1.18 |
| 11:08 ET | 5790 | 1.1898 |
| 11:09 ET | 40923 | 1.175 |
| 11:11 ET | 1900 | 1.181 |
| 11:13 ET | 110 | 1.1821 |
| 11:15 ET | 36174 | 1.21 |
| 11:18 ET | 3580 | 1.2 |
| 11:20 ET | 300 | 1.1867 |
| 11:22 ET | 200 | 1.18 |
| 11:24 ET | 280 | 1.2 |
| 11:27 ET | 1100 | 1.195 |
| 11:29 ET | 5095 | 1.21 |
| 11:31 ET | 330 | 1.2017 |
| 11:33 ET | 10126 | 1.2 |
| 11:36 ET | 5200 | 1.205 |
| 11:38 ET | 6830 | 1.205 |
| 11:40 ET | 100 | 1.205 |
| 11:42 ET | 9429 | 1.21 |
| 11:44 ET | 5300 | 1.21 |
| 11:45 ET | 18203 | 1.21 |
| 11:47 ET | 24074 | 1.22 |
| 11:49 ET | 1100 | 1.2122 |
| 11:51 ET | 13969 | 1.2152 |
| 11:54 ET | 15100 | 1.205 |
| 11:58 ET | 2600 | 1.1975 |
| 12:00 ET | 1099 | 1.22 |
| 12:03 ET | 1400 | 1.2 |
| 12:07 ET | 100 | 1.21 |
| 12:12 ET | 1919 | 1.2 |
| 12:16 ET | 500 | 1.21 |
| 12:18 ET | 3479 | 1.19 |
| 12:20 ET | 26617 | 1.19 |
| 12:21 ET | 13000 | 1.2 |
| 12:27 ET | 3628 | 1.19 |
| 12:32 ET | 3100 | 1.19 |
| 12:34 ET | 600 | 1.21 |
| 12:38 ET | 194 | 1.2008 |
| 12:39 ET | 540 | 1.1954 |
| 12:43 ET | 4100 | 1.19 |
| 12:45 ET | 600 | 1.1843 |
| 12:48 ET | 100 | 1.18 |
| 12:50 ET | 200 | 1.195 |
| 12:54 ET | 824 | 1.21 |
| 12:56 ET | 399 | 1.18 |
| 12:57 ET | 800 | 1.19 |
| 01:01 ET | 7243 | 1.19 |
| 01:03 ET | 6431 | 1.19 |
| 01:08 ET | 1599 | 1.2 |
| 01:10 ET | 575 | 1.2 |
| 01:12 ET | 1000 | 1.1914 |
| 01:14 ET | 100 | 1.2 |
| 01:17 ET | 4083 | 1.18 |
| 01:19 ET | 200 | 1.18 |
| 01:24 ET | 4101 | 1.18 |
| 01:28 ET | 1800 | 1.19 |
| 01:32 ET | 800 | 1.18 |
| 01:37 ET | 1700 | 1.19 |
| 01:39 ET | 17899 | 1.2 |
| 01:42 ET | 920 | 1.2 |
| 01:44 ET | 5100 | 1.2 |
| 01:46 ET | 416 | 1.2 |
| 01:48 ET | 1900 | 1.2 |
| 01:50 ET | 1334 | 1.195 |
| 01:51 ET | 5192 | 1.19 |
| 01:53 ET | 168 | 1.1899 |
| 01:55 ET | 9500 | 1.195 |
| 01:57 ET | 2000 | 1.195 |
| 02:02 ET | 109 | 1.19 |
| 02:08 ET | 100 | 1.2 |
| 02:09 ET | 531 | 1.2 |
| 02:13 ET | 100 | 1.2 |
| 02:15 ET | 327 | 1.2 |
| 02:18 ET | 500 | 1.21 |
| 02:20 ET | 200 | 1.21 |
| 02:22 ET | 320 | 1.1915 |
| 02:24 ET | 200 | 1.21 |
| 02:26 ET | 100 | 1.21 |
| 02:27 ET | 994 | 1.2 |
| 02:29 ET | 100 | 1.21 |
| 02:31 ET | 43903 | 1.195 |
| 02:33 ET | 500 | 1.2 |
| 02:36 ET | 100 | 1.21 |
| 02:38 ET | 1127 | 1.21 |
| 02:40 ET | 300 | 1.21 |
| 02:42 ET | 408 | 1.2099 |
| 02:44 ET | 200 | 1.21 |
| 02:47 ET | 1568 | 1.21 |
| 02:49 ET | 200 | 1.2075 |
| 02:51 ET | 410 | 1.1959 |
| 02:54 ET | 2200 | 1.2 |
| 02:56 ET | 7383 | 1.2 |
| 03:00 ET | 200 | 1.21 |
| 03:02 ET | 300 | 1.2091 |
| 03:03 ET | 200 | 1.21 |
| 03:05 ET | 408 | 1.21 |
| 03:07 ET | 200 | 1.21 |
| 03:09 ET | 3120 | 1.195 |
| 03:12 ET | 4762 | 1.195 |
| 03:14 ET | 3900 | 1.2 |
| 03:16 ET | 300 | 1.207 |
| 03:18 ET | 100 | 1.21 |
| 03:20 ET | 4300 | 1.21 |
| 03:21 ET | 200 | 1.21 |
| 03:23 ET | 910 | 1.2 |
| 03:25 ET | 300 | 1.195 |
| 03:27 ET | 10413 | 1.21 |
| 03:30 ET | 7930 | 1.21 |
| 03:32 ET | 4782 | 1.2 |
| 03:34 ET | 23046 | 1.22 |
| 03:36 ET | 11832 | 1.22 |
| 03:38 ET | 300 | 1.22 |
| 03:39 ET | 200 | 1.22 |
| 03:41 ET | 11506 | 1.21 |
| 03:43 ET | 300 | 1.23 |
| 03:45 ET | 1204 | 1.22 |
| 03:48 ET | 3090 | 1.22 |
| 03:50 ET | 4770 | 1.21 |
| 03:52 ET | 1000 | 1.22 |
| 03:54 ET | 500 | 1.22 |
| 03:56 ET | 2821 | 1.21 |
| 03:57 ET | 28966 | 1.23 |
| 03:59 ET | 1826 | 1.23 |
May 19, 2023
BRIEF-Adverum Biotechnologies- On May 18, Received Approval From Nasdaq To Transfer Listing Of Co's Common Stock Nasdaq Capital Market, from 4:31PM ET on Friday May 19, 2023 by Thomson Reuters
4:31PM ET on Friday May 19, 2023 by Thomson Reuters
May 18, 2023
Adverum Biotechnologies Presents Data on Intravitreal Gene Therapy Program for Eye Disease, from 10:48AM ET on Thursday May 18, 2023 by MT Newswires
10:48AM ET on Thursday May 18, 2023 by MT NewswiresBRIEF-Adverum Biotechnologies Introduces An Intravitreal Gene Therapy Program For Geographic Atrophy And Presents Data On Its Ocular Gene Therapy Platform, from 9:11AM ET on Thursday May 18, 2023 by Thomson Reuters
9:11AM ET on Thursday May 18, 2023 by Thomson ReutersAdverum Biotechnologies Introduces an Intravitreal Gene Therapy Program for Geographic Atrophy and Presents Data on Its Ocular Gene Therapy Platform, from 9:01AM ET on Thursday May 18, 2023 by GlobeNewswire
9:01AM ET on Thursday May 18, 2023 by GlobeNewswireAdverum Biotechnologies Presents Nonclinical Data in Support of Ixo-vec's Phase 2 Clinical Development at ASGCT 2023 Annual Meeting, from 9:01AM ET on Thursday May 18, 2023 by GlobeNewswire
9:01AM ET on Thursday May 18, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Adverum Biotechnologies Inc | 112.6M | -0.8x | --- |
Reviva Pharmaceuticals Holdings, Inc. | 112.9M | -4.5x | --- |
Talaris Therapeutics Inc | 110.9M | -1.4x | --- |
Annovis Bio Inc | 114.5M | -3.7x | --- |
Brainstorm Cell Therapeutics Inc | 115.9M | -4.3x | --- |
GlycoMimetics Inc | 115.6M | -2.4x | --- |
Company Information
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company. The Company discovers and develops gene therapy product candidates that provides durable efficacy by inducing sustained expression of a therapeutic protein for ocular diseases. Its lead product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable levels of aflibercept associated with a sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) IVT injections. Ixo-vec is being developed for the treatment of patients with wet age-related macular degeneration (wet AMD) who are responsive to anti-VEGF therapy. Its second product candidate, ADVM-062 (AAV.7m8-L-opsin), is a gene therapy product candidate being developed to treat patients suffering from blue cone monochromacy (BCM) via a single IVT injection.
Contact Information
- Headquarters
- 100 Cardinal WayREDWOOD CITY, CA, United States 94063
- Phone
- 650-649-1004
- Fax
- 650-329-8151
Executives
- Independent Chairman of the Board
- Patrick Machado
- President, Chief Executive Officer, Director
- Laurent Fischer
- Chief Financial Officer
- Linda Rubinstein
- Chief Operating Officer
- Kishor Soparkar
- Chief Scientific Officer
- Brigit Riley
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $112.6M |
|---|---|
Revenue (TTM) | $3.6M |
Shares Outstanding | 100.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.73 |
EPS | $-1.46 |
Book Value | $1.81 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | 31.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -4,145.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
